412 related articles for article (PubMed ID: 30022544)
1. A randomized, intraindividual, non-inferiority, Phase III study comparing daylight photodynamic therapy with BF-200 ALA gel and MAL cream for the treatment of actinic keratosis.
Dirschka T; Ekanayake-Bohlig S; Dominicus R; Aschoff R; Herrera-Ceballos E; Botella-Estrada R; Hunfeld A; Kremser M; Schmitz B; Lübbert H; Puig S
J Eur Acad Dermatol Venereol; 2019 Feb; 33(2):288-297. PubMed ID: 30022544
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo.
Dirschka T; Radny P; Dominicus R; Mensing H; Brüning H; Jenne L; Karl L; Sebastian M; Oster-Schmidt C; Klövekorn W; Reinhold U; Tanner M; Gröne D; Deichmann M; Simon M; Hübinger F; Hofbauer G; Krähn-Senftleben G; Borrosch F; Reich K; Berking C; Wolf P; Lehmann P; Moers-Carpi M; Hönigsmann H; Wernicke-Panten K; Helwig C; Foguet M; Schmitz B; Lübbert H; Szeimies RM;
Br J Dermatol; 2012 Jan; 166(1):137-46. PubMed ID: 21910711
[TBL] [Abstract][Full Text] [Related]
3. Combined daylight and conventional photodynamic therapy with 5-aminolaevulinic acid nanoemulsion (BF-200 ALA) for actinic keratosis of the face and scalp: a new and efficient approach.
Salido-Vallejo R; Jiménez-Nájar F; Garnacho-Sucedo G; Vélez A
Arch Dermatol Res; 2020 Nov; 312(9):675-680. PubMed ID: 31838569
[TBL] [Abstract][Full Text] [Related]
4. 5-aminolaevulinic acid nanoemulsion is more effective than methyl-5-aminolaevulinate in daylight photodynamic therapy for actinic keratosis: a nonsponsored randomized double-blind multicentre trial.
Räsänen JE; Neittaanmäki N; Ylitalo L; Hagman J; Rissanen P; Ylianttila L; Salmivuori M; Snellman E; Grönroos M
Br J Dermatol; 2019 Aug; 181(2):265-274. PubMed ID: 30329163
[TBL] [Abstract][Full Text] [Related]
5. Daylight photodynamic therapy for actinic keratoses: a randomized double-blinded nonsponsored prospective study comparing 5-aminolaevulinic acid nanoemulsion (BF-200) with methyl-5-aminolaevulinate.
Neittaanmäki-Perttu N; Karppinen TT; Grönroos M; Tani TT; Snellman E
Br J Dermatol; 2014 Nov; 171(5):1172-80. PubMed ID: 25109244
[TBL] [Abstract][Full Text] [Related]
6. Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis.
Dirschka T; Radny P; Dominicus R; Mensing H; Brüning H; Jenne L; Karl L; Sebastian M; Oster-Schmidt C; Klövekorn W; Reinhold U; Tanner M; Gröne D; Deichmann M; Simon M; Hübinger F; Hofbauer G; Krähn-Senftleben G; Borrosch F; Reich K; Berking C; Wolf P; Lehmann P; Moers-Carpi M; Hönigsmann H; Wernicke-Panten K; Hahn S; Pabst G; Voss D; Foguet M; Schmitz B; Lübbert H; Szeimies RM; ;
Br J Dermatol; 2013 Apr; 168(4):825-36. PubMed ID: 23252768
[TBL] [Abstract][Full Text] [Related]
7. A randomized, multinational, noninferiority, phase III trial to evaluate the safety and efficacy of BF-200 aminolaevulinic acid gel vs. methyl aminolaevulinate cream in the treatment of nonaggressive basal cell carcinoma with photodynamic therapy.
Morton CA; Dominicus R; Radny P; Dirschka T; Hauschild A; Reinhold U; Aschoff R; Ulrich M; Keohane S; Ekanayake-Bohlig S; Ibbotson S; Ostendorf R; Berking C; Gröne D; Schulze HJ; Ockenfels HM; Jasnoch V; Kurzen H; Sebastian M; Stege H; Staubach P; Gupta G; Hübinger F; Ziabreva I; Schmitz B; Gertzmann A; Lübbert H; Szeimies RM
Br J Dermatol; 2018 Aug; 179(2):309-319. PubMed ID: 29432644
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind, phase III, multicentre study to evaluate the safety and efficacy of BF-200 ALA (Ameluz(®) ) vs. placebo in the field-directed treatment of mild-to-moderate actinic keratosis with photodynamic therapy (PDT) when using the BF-RhodoLED(®) lamp.
Reinhold U; Dirschka T; Ostendorf R; Aschoff R; Berking C; Philipp-Dormston WG; Hahn S; Lau K; Jäger A; Schmitz B; Lübbert H; Szeimies RM
Br J Dermatol; 2016 Oct; 175(4):696-705. PubMed ID: 26921093
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of photodynamic therapy with amino-5-laevulinate nanoemulsion versus methyl-5-aminolaevulinate for actinic keratosis: A meta-analysis.
Fu C; Kuang BH; Qin L; Zeng XY; Wang BC
Photodiagnosis Photodyn Ther; 2019 Sep; 27():408-414. PubMed ID: 31310826
[TBL] [Abstract][Full Text] [Related]
10. Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial.
Rubel DM; Spelman L; Murrell DF; See JA; Hewitt D; Foley P; Bosc C; Kerob D; Kerrouche N; Wulf HC; Shumack S
Br J Dermatol; 2014 Nov; 171(5):1164-71. PubMed ID: 24861492
[TBL] [Abstract][Full Text] [Related]
11. Home- vs clinic-based daylight photodynamic therapy with 5-aminolevulinic acid nanoemulsion (BF-200 ALA) for actinic keratosis: A randomized, single-blind, prospective study.
Saenz-Guirado S; Ayen-Rodriguez A; Galvez-Moreno M; Velasco-Amador JP; Llamas-Molina JM; Ruiz-Villaverde R; Molina-Leyva A
Photodiagnosis Photodyn Ther; 2024 Apr; 46():104031. PubMed ID: 38438001
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic therapy of actinic keratoses with 8% and 16% methyl aminolaevulinate and home-based daylight exposure: a double-blinded randomized clinical trial.
Wiegell SR; Haedersdal M; Eriksen P; Wulf HC
Br J Dermatol; 2009 Jun; 160(6):1308-14. PubMed ID: 19416257
[TBL] [Abstract][Full Text] [Related]
13. Artificial White Light vs Daylight Photodynamic Therapy for Actinic Keratoses: A Randomized Clinical Trial.
O'Gorman SM; Clowry J; Manley M; McCavana J; Gray L; Kavanagh A; Lally A; Collins P
JAMA Dermatol; 2016 Jun; 152(6):638-44. PubMed ID: 26843523
[TBL] [Abstract][Full Text] [Related]
14. Combination of ablative fractional laser and daylight-mediated photodynamic therapy for actinic keratosis in organ transplant recipients - a randomized controlled trial.
Togsverd-Bo K; Lei U; Erlendsson AM; Taudorf EH; Philipsen PA; Wulf HC; Skov L; Hædersdal M
Br J Dermatol; 2015 Feb; 172(2):467-74. PubMed ID: 24975199
[TBL] [Abstract][Full Text] [Related]
15. A review of BF-200 ALA for the photodynamic treatment of mild-to-moderate actinic keratosis.
Reinhold U
Future Oncol; 2017 Nov; 13(27):2413-2428. PubMed ID: 28805092
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and safety of 0·5% colchicine cream vs. photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratosis and skin field cancerization of the forearms: a randomized controlled trial.
Miola AC; Ferreira ER; Lima TRR; Schmitt JV; Abbade LPF; Miot HA
Br J Dermatol; 2018 Nov; 179(5):1081-1087. PubMed ID: 29862491
[TBL] [Abstract][Full Text] [Related]
17. Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator-blinded, controlled, phase III study throughout Europe.
Lacour JP; Ulrich C; Gilaberte Y; Von Felbert V; Basset-Seguin N; Dreno B; Girard C; Redondo P; Serra-Guillen C; Synnerstad I; Tarstedt M; Tsianakas A; Venema AW; Kelleners-Smeets N; Adamski H; Perez-Garcia B; Gerritsen MJ; Leclerc S; Kerrouche N; Szeimies RM
J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):2342-8. PubMed ID: 26435363
[TBL] [Abstract][Full Text] [Related]
18. Randomized, double-blind, prospective study to compare topical 5-aminolaevulinic acid methylester with topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratosis.
Moloney FJ; Collins P
Br J Dermatol; 2007 Jul; 157(1):87-91. PubMed ID: 17501954
[TBL] [Abstract][Full Text] [Related]
19. Update on photodynamic treatment for actinic keratosis.
Wiegell SR
Curr Probl Dermatol; 2015; 46():122-8. PubMed ID: 25561216
[TBL] [Abstract][Full Text] [Related]
20. Plum-blossom needle tapping enhances the efficacy of ALA photodynamic therapy for facial actinic keratosis in Chinese population: a randomized, multicenter, prospective, and observer-blind study.
Wang P; Xie F; Zhang L; Zhao S; Zhu L; Shen S; Li D; Chen Z; Xiao R; Lu Y; Lei X; Li Y; Zhang G; Zeng W; Wang X
Photodiagnosis Photodyn Ther; 2023 Jun; 42():103611. PubMed ID: 37211296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
